Analysts Forecast Significant Upside for Vanguard ETF Holdings

Analysts see a 13.55% upside for the Vanguard Small-Cap ETF (VB), trading at $251.26 while its target price stands at $285.31. This optimistic outlook may influence investor sentiment and stock prices.

Date: 23-01-2025

AI Rating: 7

Upside Potential
The Vanguard Small-Cap ETF (VB) is currently trading at $251.26, significantly below the analysts' 12-month target price of $285.31, indicating a potential increase of 13.55%. Such projections may attract investors looking for growth opportunities.

Underlying Holdings
Notably, three of VB's underlying holdings present substantial upside compared to their target prices: CG Oncology Inc (CGON) shows potential of 118.88% increase with a target of $66.12 from its recent price of $30.21; Biohaven Ltd (BHVN) has a target price of $64.38, reflecting a 58.74% upside from $40.56; and BrightSpire Capital Inc (BRSP) has an expected gain of 31.30% reaching $7.37 from its current price of $5.61. These figures might encourage investors to consider these stocks for their portfolios.

In the report, analysts emphasize the necessity for further research regarding these optimism levels, suggesting that the high target prices relative to actual trading prices could be an indicator of either genuine growth potential or an overly optimistic outlook. The relevance of such an evaluation informs investor decision-making processes.

Stocks: VB CGON BHVN BRSP